We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRSO:NASDAQPeraso Inc. Analysis

Data as of 2026-06-12 - not real-time

$0.99

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Peraso Inc. (PRSO) is trading at $0.99, well below its 20‑day SMA of $1.03 and the 200‑day SMA of $1.09, indicating a price that is lagging both short‑ and long‑term averages. The RSI sits at roughly 47, suggesting neutral momentum, while the MACD histogram is negative and the MACD line sits below its signal, reinforcing a bearish technical bias. Volume has been on a downward trend and 30‑day volatility is extreme at over 145%, highlighting a highly erratic price environment. Recent earnings released a 74% YoY revenue collapse to $1.0 M, though gross margin improved to 61.5% and management signaled a modest Q2 revenue rebound to about $1.2 M. The company’s balance sheet shows modest cash of $2.7 M against minimal debt, but operating and net margins remain deeply negative, and free cash flow is essentially zero. Valuation metrics are distorted by negative earnings, yet the consensus target price of $2.75 implies a potential upside of more than 170% from current levels. The semiconductor sector is inherently cyclical and exposed to supply‑chain and regulatory headwinds, adding sector‑specific risk. Beta is slightly negative, indicating low correlation with broader market moves, but the stock’s micro‑cap size and thin trading depth raise liquidity concerns. Overall, PRSO presents a speculative play: technicals are bearish, fundamentals are weak, but the upside potential embedded in analyst targets and a nascent revenue recovery could reward risk‑tolerant investors.
Investors should weigh the stark earnings deficits and volatile price action against the strategic positioning in mmWave technology and the sizable upside implied by price targets. The lack of dividends, high volatility, and modest cash runway suggest caution, while the company’s focus on diversifying suppliers and expanding into resilient high‑capacity networking markets may provide a longer‑term growth narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • price below short‑term moving averages
  • bearish MACD and decreasing volume
  • extreme short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • expected Q2 revenue rebound
  • analyst target price indicating >170% upside
  • improved gross margin despite revenue dip

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • strategic positioning in growing mmWave market
  • low beta suggesting limited market‑wide downside
  • cash cushion to support continued R&D

Key Metrics & Analysis

Financial Health

Revenue Growth-75.10%
Profit Margin-73.00%
P/E Ratio-6.0
ROE-165.40%
ROA-66.21%
Debt/Equity3.45
P/B Ratio2.2
Industry P/E36.5

Technical Analysis

TrendNeutral
RSI47.0
Support$0.92
Resistance$1.21
MA 20$1.03
MA 50$1.01
MA 200$1.09
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Target Price$2.75
Upside/Downside178.06%
GradeUndervalued
TypeBlend

Risk Assessment

Beta-0.19
Volatility145.83%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.